GGrantIndex
Sort

261,768 grants matching gene therapy

Trial of Statins for Chemoprevention in Hepatocellular Carcinoma

$1,487,531
Raymond T Chung · Massachusetts General Hospital · R01 · FY2025 · CA

Leukemia Signatures for Risk Classification &Targeting

$1,487,298
University Of New Mexico · U01 · FY2005 · CA

The Miami Center for AIDS Research

$1,487,266
Savita Pahwa · University Of Miami School Of Medicine · P30 · FY2015 · AI

Single Cell Transcriptomics of the Cocaine Use Disorder in the Context of HIV

$1,487,129
Christine Cheng · University Of California, San Diego · U01 · FY2024 · DA

Prospective Study of Breast Cancer Survivorship

$1,487,114
Kaiser Foundation Research Institute · R01 · FY2004 · CA

Studies of Hereditary Neurological Disease: Disease Mechanisms

$1,487,067
Kenneth Fischbeck · National Institute Of Neurological Disorders And Stroke · ZIA · FY2012 · NS

Center of Research Translation in Muscular Dystrophy Therapeutic Development

$1,487,033
Kevin M Flanigan · Research Inst Nationwide Children'S Hosp · P50 · FY2017 · AR

Regulation of Ras-Dependent Signal Transduction Pathways

$1,486,526
Deborah Morrison · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

Immunoglobulin Light Chain Fibrillogenesis

$1,486,491
Boston University Medical Campus · P01 · FY2002 · HL

PATHOBIOLOGY AND GENE TRANSFER IN CARDIOVASCULAR DISEASE

$1,486,224
Baylor College Of Medicine · P01 · FY2003 · HL

Mouse Mutant Resource

$1,485,983
Leah Rae B Donahue · Jackson Laboratory · P40 · FY2010 · RR

Comparative Analysis of Genetics of Stress Response and Reward

$1,485,908
Christina Barr · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2020 · AA

Nasal microRNA during bronchiolitis and age 6y asthma phenotypes: MARC-35 cohort

$1,485,833
Carlos A. Camargo · Massachusetts General Hospital · R01 · FY2020 · AI

Genotype and Phenotype of Response to Treatments of Autism

$1,485,825
University Of Rochester · U54 · FY2004 · MH

PIDTC Administrative Unit

$1,485,717
Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2019 · AI

Pharmacogenomics of Anti-platelet Agents for CVD Prevent

$1,485,240
Alan R. Shuldiner · University Of Maryland Baltimore · U01 · FY2006 · GM

Gene Therapy Approaches for Primary Immunodeficiencies

$1,485,215
Fabio Candotti · National Human Genome Research Institute · ZIA · FY2011 · HG

Regenerative Scaffold Technologies for CNS and Diabetes

$1,485,127
Northwestern University · R01 · FY2005 · EB

Preclinical Development of an Anti-Mucus Drug

$1,485,085
Michael Jay Holtzman · Washington University · UH2 · FY2015 · HL

Prostate Cancer: Transition to Androgen - Independence (CA77739)

$1,485,030
Frank S French · Univ Of North Carolina Chapel Hill · P01 · FY2012 · CA

UNMC Eppley Cancer Center Support Grant

$1,485,000
Kenneth Cowan · University Of Nebraska Medical Center · P30 · FY2015 · CA

UNMC Eppley Cancer Center Support Grant

$1,485,000
Kenneth Cowan · University Of Nebraska Medical Center · P30 · FY2014 · CA

Investigations of Methylmalonic Acidemia and Related Disorders

$1,484,928
Charles P Venditti · National Human Genome Research Institute · ZIA · FY2014 · HG

The Colon Cancer Family Registry: Australasia

$1,484,815
John L Hopper · University Of Melbourne · U24 · FY2008 · CA

A Pilot Clinical Study in Acute STEMI

$1,484,711
Weizhong Cai · Angion Biomedica Corporation · R44 · FY2011 · HL